Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $19.5 Million - $22.8 Million
-279,535 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $28.6 Million - $32.6 Million
-411,225 Reduced 59.53%
279,535 $23.2 Million
Q4 2018

Feb 14, 2019

SELL
$65.24 - $75.71 $6.49 Million - $7.53 Million
-99,469 Reduced 12.59%
690,760 $52.8 Million
Q3 2018

Nov 14, 2018

BUY
$57.69 - $67.84 $2.31 Million - $2.72 Million
40,128 Added 5.35%
790,229 $56.1 Million
Q2 2018

Aug 14, 2018

BUY
$50.83 - $59.72 $50,677 - $59,540
997 Added 0.13%
750,101 $45.5 Million
Q1 2018

May 15, 2018

BUY
$50.96 - $59.23 $3.53 Million - $4.11 Million
69,357 Added 10.2%
749,104 $40.8 Million
Q4 2017

Feb 14, 2018

BUY
$51.62 - $61.64 $6.15 Million - $7.34 Million
119,053 Added 21.23%
679,747 $38.2 Million
Q3 2017

Nov 14, 2017

BUY
$58.67 - $63.13 $32.9 Million - $35.4 Million
560,694
560,694 $35.9 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $223B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Orbis Allan Gray LTD Portfolio

Follow Orbis Allan Gray LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbis Allan Gray LTD, based on Form 13F filings with the SEC.

News

Stay updated on Orbis Allan Gray LTD with notifications on news.